| Literature DB >> 30115827 |
Lindsay N Kohler1,2, Robin B Harris3,4, Eyal Oren5,6, Denise J Roe7,8, Peter Lance9, Elizabeth T Jacobs10,11.
Abstract
Adherence to the American Cancer Society's (ACS) Nutrition and Physical Activity Cancer Prevention Guidelines is associated with reductions in overall cancer incidence and mortality, including site-specific cancers such as colorectal cancer. We examined the relationship between baseline adherence to the ACS guidelines and (1) baseline adenoma characteristics and (2) odds of recurrent colorectal adenomas over 3 years of follow-up. Cross-sectional and prospective analyses with a pooled sample of participants from the Wheat Bran Fiber (n = 503) and Ursodeoxycholic Acid (n = 854) trials were performed. A cumulative adherence score was constructed using baseline self-reported data regarding body size, diet, physical activity and alcohol consumption. Multivariable logistic regression demonstrated significantly reduced odds of having three or more adenomas at baseline for moderately adherent (odds ratio [OR] = 0.67, 95% confidence intervals [CI]: 0.46⁻0.99) and highly adherent (OR = 0.50, 95% CI: 0.31⁻0.81) participants compared to low adherers (p-trend = 0.005). Conversely, guideline adherence was not associated with development of recurrent colorectal adenoma (moderate adherence OR = 1.16, 95% CI: 0.85⁻1.59, high adherence OR = 1.23, 95% CI: 0.85⁻1.79).Entities:
Keywords: adherence; cancer prevention guidelines; colorectal adenoma; diet; physical activity
Mesh:
Year: 2018 PMID: 30115827 PMCID: PMC6115749 DOI: 10.3390/nu10081098
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Components of the guideline adherence score and distribution in the study sample.
| Score | Description | All | |
|---|---|---|---|
| Overall adherence score | Low | 0–2 points | 204 (12.2) |
| Moderate | 3–5 points | 1147 (68.7) | |
| High | 6–8 points | 319 (19.1) | |
| Adherence score component | |||
| Body mass index (BMI) | 0 | >30 kg/m2 | 476 (28.5) |
| 1 | >25–≤30 kg/m2 | 749 (44.9) | |
| 2 | 18.5–≤25 kg/m2 | 445 (26.7) | |
| Physical Activity (PA) | 0 | <8.75 MET h/week | 658 (39.4) |
| 1 | 8.75–17.5 MET h/week | 421 (25.2) | |
| 2 | >17.5 MET h/week | 591 (35.4) | |
| Overall Diet 1 | 0 | 0–1 sub-score sum | 209 (12.5) |
| 1 | 2–4 sub-score sum | 947 (56.7) | |
| 2 | 5–6 sub-score sum | 514 (30.8) | |
| Fruit & Vegetables sub-score | 0 | <5 servings/day fruits plus veg | 836 (50.1) |
| 1 | ≥5 servings/day fruits plus veg | 834 (49.9) | |
| Quality sub-score | 0 | 1st tertile of total carotenoids | 540 (32.3) |
| 1 | 2nd tertile of total carotenoids | 564 (33.8) | |
| 2 | 3rd tertile of total carotenoids | 566 (33.9) | |
| Red & processed meat sub-score | 0 | Highest quartile | 421 (25.2) |
| 1 | 423 (25.3) | ||
| 2 | 420 (25.2) | ||
| 3 | Lowest quartile | 406 (24.3) | |
| Alcohol | 0 | Men ≥3, Women ≥2 drinks/day | 153 (9.2) |
| 1 | Men 1–2, Women 1 drink/day | 921 (55.2) | |
| 2 | Non-drinker | 596 (35.7) |
1 Overall Diet score is generated from the summation of the fruit & vegetable, quality and red & processed meat sub-scores then collapsed into 3 categories (0–1, 2–4, 5–6) for subsequent overall diet adherence scores (0, 1, 2).
Baseline characteristics of participants in the pooled sample, by categories of adherence 1.
| Adherence Score Category (Points) | |||
|---|---|---|---|
| 0–2 | 3–5 | 6–8 | |
| 204 (12.2) | 1147 (68.7) | 319 (19.1) | |
| Age, years 2 | 62.8 ± 8.4 | 65.8 ± 8.6 | 68.0 ± 8.1 * |
| White, | 195 (95.6) | 1085 (94.6) | 303 (95.0) |
| College graduate, | 60 (29.4) | 409 (35.7) | 113 (35.4) |
| BMI, kg/m2 | 32.5 ± 4.4 | 28.2 ± 4.3 | 24.5 ± 2.7 * |
| Physical activity, MET-h/week | 4.1 ± 5.0 | 16.7 ± 29.2 | 31.3 ± 32.2 * |
| Diet | |||
| Total energy, kcal/day | 2135 ± 797 | 1955 ± 757 | 1946 ± 726 * |
| Fruit and veg, servings/day | 5.0 ± 3.3 | 5.7 ± 3.7 | 6.9 ± 3.7 * |
| Total carotenoids, mg/day | 13.4 ± 9.1 | 13.8 ± 8.7 | 15.1 ± 7.4 * |
| Red and processed meat, servings/day | 2.0 ± 1.0 | 1.4 ± 0.8 | 1.1 ± 0.7 * |
| Alcohol | |||
| Nondrinker at baseline, | 22 (10.8) | 391 (34.1) | 183 (57.4) * |
| Intake among drinkers, drinks/day | 1.3 ± 1.7 | 0.8 ± 1.2 | 0.7 ± 0.7 * |
| Current smoker, | 34 (16.7) | 137 (11.9) | 38 (11.9) |
| Family history CRC, | 51 (25.0) | 267 (23.3) | 66 (20.7) |
| Previous polyps, | 78 (38.2) | 489 (42.6) | 131 (41.1) |
| Aspirin use in last 4 weeks, | 49 (24.0) | 340 (29.6) | 113 (35.4) * |
| Number of colonoscopies during study period | 1.8 ± 0.8 | 1.8 ± 0.8 | 1.8 ± 0.9 |
| Baseline adenoma characteristics | |||
| Multiplicity, ≥3 adenomas, | 42 (15.0) | 192 (68.3) | 47 (16.7) |
| Large size, >1cm, | 89 (13.1) | 463 (67.9) | 130 (19.1) |
| Tubulovillous/villous histology, | 49 (14.1) | 228 (65.5) | 71 (20.4) |
| Proximal location, | 109 (12.8) | 594 (69.6) | 150 (17.6) |
1 Some percentages do not add up to 100% because of missing data or rounding. BMI, body mass index; MET-h/week, metabolic equivalent hours per week; CRC, colorectal cancer. 2 Mean ± SD (all such values). * p-value < 0.05. Non-parametric test for trend for continuous variables and ANOVA for categorical variables.
Adjusted ORs (95% CI) for the association between category of guideline adherence and baseline colorectal adenoma characteristics for pooled sample and by sex and study.
| Baseline Adenoma Characteristics (OR, 95% CI) 1 | ||||||
|---|---|---|---|---|---|---|
| Acs Adherence Score Category | Multiplicity (≥3 Adenoma) | Large Size (≥1 cm) | Villous Histology | |||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Pooled sample | ||||||
| Low (0–2) | 204 (12.2) | 1.00 | 89 (13.1) | 1.00 | 49 (14.1) | 1.00 |
| Moderate (3–5) | 1147 (68.7) | 0.67 (0.46–0.99) | 463 (67.9) | 0.85 (0.63–1.15) | 228 (65.5) | 0.78 (0.55–1.11) |
| High (6–8) | 319 (19.1) | 0.50 (0.31–0.81) | 130 (19.1) | 0.85 (0.59–1.22) | 71 (20.4) | 0.89 (0.58–1.36) |
| 0.005 | 0.455 | 0.765 | ||||
| Men | ||||||
| Low (0–2) | 141 (12.3) | 1.00 | 57 (12.3) | 1.00 | 34 (14.5) | 1.00 |
| Moderate (3–5) | 791 (68.7) | 0.62 (0.40–0.97) | 319 (69.1) | 0.92 (0.64–1.34) | 153 (65.4) | 0.73 (0.47–1.12) |
| High (6–8) | 219 (19.0) | 0.47 (0.27–0.82) | 86 (18.6) | 0.83 (0.53–1.30) | 47 (20.1) | 0.78 (0.46–1.30) |
| 0.011 | 0.405 | 0.443 | ||||
| Women | ||||||
| Low (0–2) | 63 (12.1) | 1.00 | 32 (14.6) | 1.00 | 15 (13.2) | 1.00 |
| Moderate (3–5) | 356 (68.6) | 0.82 (0.38–1.79) | 144 (65.5) | 0.68 (0.40–1.17) | 75 (65.8) | 0.90 (0.48–1.70) |
| High (6–8) | 100 (19.3) | 0.56 (0.21–1.48) | 44 (20.0) | 0.85 (0.45–1.60) | 24 (21.1) | 1.16 (0.55–2.45) |
| 0.221 | 0.809 | 0.577 | ||||
| 0.8360 | 0.4363 | 0.8597 | ||||
1 ORs adjusted for age, sex (except for stratified analysis) and study (except for stratified analysis), 2 p for interaction calculated by likelihood ratio test.
Adjusted ORs (95% CIs) for the association between category of adherence and recurrent colorectal adenoma occurrence for pooled sample and by sex and study.
| Recurrent Adenoma Occurrence (OR, 95% CI) 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Adherence Score Category | Any Recurrent Adenoma | Multiplicity (≥3 Adenoma) | Large Size (≥1 cm) | Villous Histology | |||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||||
| Pooled sample | |||||||||
| Low (0–2) | 105 (13.8) | 1.00 | 22 (11.2) | 1.00 | 14 (8.4) | 1.00 | 11 (9.2) | 1.00 | |
| Moderate (3–5) | 504 (66.2) | 1.16 (0.85–1.59) | 130 (66.0) | 0.97 (0.58–1.59) | 112 (67.1) | 1.40 (0.78–2.51) | 88 (73.3) | 1.35 (0.70–2.58) | |
| High (6–8) | 152 (20.0) | 1.23 (0.85–1.79) | 45 (22.8) | 1.11 (0.62–1.98) | 41 (24.6) | 1.83 (0.95–3.51) | 21 (17.5) | 1.08 (0.50–2.33) | |
| 0.294 | 0.611 | 0.055 | 0.938 | ||||||
| Men | |||||||||
| Low (0–2) | 67 (11.9) | 1.00 | 18 (11.6) | 1.00 | 12 (9.6) | 1.00 | 10 (11.1) | 1.00 | |
| Moderate (3–5) | 385 (38.4) | 1.00 (0.69–1.45) | 98 (63.2) | 0.85 (0.48–1.49) | 85 (68.0) | 1.12 (0.59–2.15) | 65 (72.2) | 1.00 (0.50–2.02) | |
| High (6–8) | 111 (19.7) | 1.00 (0.64–1.56) | 39 (25.2) | 1.10 (0.58–2.12) | 28 (22.4) | 1.27 (0.61–2.67) | 15 (16.7) | 0.76 (0.32–1.77) | |
| 0.983 | 0.531 | 0.494 | 0.435 | ||||||
| Women | |||||||||
| Low (0–2) | 17 (8.6) | 1.00 | 4 (9.5) | 1.00 | 2 (4.8) | 1.00 | 1 (3.3) | 1.00 | |
| Moderate (3–5) | 138 (69.7) | 1.69 (0.92–3.09) | 32 (76.2) | 1.30 (0.43–3.89) | 27 (64.3) | 2.45 (0.56–10.64) | 23 (76.7) | 4.42 (0.58–33.38) | |
| High (6–8) | 43 (21.7) | 2.02 (1.01–4.06) | 6 (14.3) | 0.92 (0.25–3.40) | 13 (31.0) | 4.58 (0.98–21.39) | 6 (20.0) | 4.15 (0.48–35.56) | |
| 0.061 | 0.750 | 0.021 | 0.306 | ||||||
| 0.2152 | 0.3877 | 0.3253 | 0.1281 | ||||||
1 ORs adjusted for age, study (except for stratified analysis), baseline multiplicity (except villous histology analyses) and sex (except for stratified analysis). 2 p for interaction calculated by likelihood ratio test.